Burleson & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.48M | Buy |
48,470
+25,808
| +114% | +$1.32M | 0.62% | 47 |
|
|
2022
Q3 | $992K | Buy |
22,662
+4,676
| +26% | +$205K | 0.21% | 76 |
|
|
2022
Q2 | $943K | Buy |
17,986
+47
| +0.3% | +$2.46K | 0.2% | 76 |
|
|
2022
Q1 | $929K | Sell |
17,939
-410
| -2% | -$21.2K | 0.15% | 84 |
|
|
2021
Q4 | $1.08M | Buy |
18,349
+29
| +0.2% | +$1.71K | 0.16% | 77 |
|
|
2021
Q3 | $788K | Buy |
18,320
+170
| +0.9% | +$7.31K | 0.12% | 75 |
|
|
2021
Q2 | $711K | Buy |
18,150
+2,167
| +14% | +$84.9K | 0.1% | 83 |
|
|
2021
Q1 | $579K | Sell |
15,983
-77
| -0.5% | -$2.79K | 0.09% | 92 |
|
|
2020
Q4 | $591K | Sell |
16,060
-573
| -3% | -$21.1K | 0.1% | 96 |
|
|
2020
Q3 | $574K | Sell |
16,633
-5,246
| -24% | -$181K | 0.11% | 94 |
|
|
2020
Q2 | $798K | Sell |
21,879
-936
| -4% | -$34.1K | 0.17% | 87 |
|
|
2020
Q1 | $806K | Sell |
22,815
-2,563
| -10% | -$90.5K | 0.21% | 79 |
|
|
2019
Q4 | $968K | Buy |
25,378
+19
| +0.1% | +$725 | 0.27% | 81 |
|
|
2019
Q3 | $885K | Buy |
25,359
+20
| +0.1% | +$698 | 0.31% | 69 |
|
|
2019
Q2 | $920K | Buy |
25,339
+17
| +0.1% | +$617 | 0.39% | 61 |
|
|
2019
Q1 | $994K | Buy |
25,322
+17
| +0.1% | +$667 | 0.42% | 56 |
|
|
2018
Q4 | $1.01M | Sell |
25,305
-5,379
| -18% | -$215K | 0.52% | 49 |
|
|
2018
Q3 | $1.29M | Buy |
30,684
+5,009
| +20% | +$210K | 0.72% | 41 |
|
|
2018
Q2 | $884K | Buy |
25,675
+1,398
| +6% | +$48.1K | 0.52% | 57 |
|
|
2018
Q1 | $817K | Buy |
24,277
+1,477
| +6% | +$49.7K | 0.53% | 59 |
|
|
2017
Q4 | $784K | Buy |
+22,800
| New | +$784K | 0.5% | 59 |
|